Clinical Studies of Lysergic Acid Diethylamide
Anderson, E. W., & Rawnsley, K. (1954). Clinical studies of lysergic acid diethylamide. European Neurology, 128(1-2), 38-55.
Anderson, E. W., & Rawnsley, K. (1954). Clinical studies of lysergic acid diethylamide. European Neurology, 128(1-2), 38-55.
1. 5-Hydroxytryptamine (HT) caused vasoconstriction and bronchoconstriction in cats’ lungs perfused with blood. These actions were antagonized by dihydroergotamine or lysergic acid diethylamide.
4. When the rate of circulation was increased the rate of disappearance of HT rose.
Gaddum, J. H., Hebb, C. O., Silver, A., & Swan, A. A. B. (1953). 5‐Hydroxytryptamine. Pharmacological action and destruction in perfused lungs. Quarterly journal of experimental physiology and cognate medical sciences, 38(4), 255-262. https://dx.doi.org/10.1113/expphysiol.1953.sp001037
Link to full text
Deshon, H. J., Rinkel, M., & Solomon, H. C. (1952). Mental changes experimentally produced by LSD (d-lysergic acid diethylamide tartrate). Psychiatric Quarterly, 26(1), 33-53., 10.1007/BF01568448
Link to full text
Guttmann, E. R. I. C. H., & Maclay, W. S. (1936). Mescalin and depersonalization: Therapeutic experiments. Journal of Neurology and Psychopathology, 16(63), 193.
Link to full text
Mitchell, S. W. (1896). Remarks on the effects of Anhelonium lewinii (the mescal button). British Medical Journal, 2(1875), 1625.
Link to full text